Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
10
Fiscal Year
2002
Total Cost
$197,422
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chesler, Louis; Goldenberg, David D; Seales, Isha T et al. (2007) Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res 67:9435-42
Ertsey, Robert; Chapin, Cheryl J; Kitterman, Joseph A et al. (2004) Ontogeny of poly(ADP-ribose) polymerase-1 in lung and developmental implications. Am J Respir Cell Mol Biol 30:853-61
Loh, Mignon L; Vattikuti, Shashaank; Schubbert, Suzanne et al. (2004) Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103:2325-31
Scavo, Louis M; Newman, Valerie; Ertsey, Robert et al. (2003) Maternally administered dexamethasone transiently increases apoptosis in lungs of fetal rats. Exp Lung Res 29:211-26
Loh, Mignon L; Rubnitz, Jeffrey E (2002) TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol 9:345-52
McQuillen, Patrick S; DeFreitas, Michael F; Zada, Gabriel et al. (2002) A novel role for p75NTR in subplate growth cone complexity and visual thalamocortical innervation. J Neurosci 22:3580-93
Loh, Mignon L; Ahn, Peter; Perez-Atayde, Antonio R et al. (2002) Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, Boston. J Pediatr Hematol Oncol 24:722-6
Xie, Y; Yeo, T T; Zhang, C et al. (2001) The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo. J Neurosci 21:5130-8
DeFreitas, M F; McQuillen, P S; Shatz, C J (2001) A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons. J Neurosci 21:5121-9
Tworetzky, W; Moore, P; Bekker, J M et al. (2000) Pulmonary blood flow alters nitric oxide production in patients undergoing device closure of atrial septal defects. J Am Coll Cardiol 35:463-7

Showing the most recent 10 out of 28 publications